Pliant Therapeutics PLRX
NASDAQ PLRX
$1.08 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) EV to FCF (2020)

Updated

Pliant Therapeutics' (PLRX) EV to FCF was 34.34 for Q3 2020, up 545.1% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) EV to FCF (2020) Analysis & Trends

Over the twelve months ended Sep 30, 2020, Pliant Therapeutics' EV to FCF came in at 54.17.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pliant Therapeutics 66.87 Mn 66.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 34.34
Jun 30, 2020 5.32
API Access

Pliant Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=PLRX&period=max&api_key=YOUR_API_KEY